Market Chatter: US Biosecure Act Passage Still Looms Despite Trump Win, WuXi AppTec Executive Says

MT Newswires Live11-20 11:01

The victory of US President-elect Donald Trump will not directly impact the US Biosecure Act, Yicai Global reported, citing WuXi AppTec (HKG:2359, SHA:603259) Vice Chairman and Chief Investment Officer Hu Zhengguo.

Passage of the US Biosecure Act, aimed at restricting US federal agencies from transacting with Chinese biotechnology firms due to probable security risks, is still uncertain as Congress adjourns in January 2025, the report said, citing Hu.

The bill still needs to pass through the Senate before the president signs it into law.

However, the impending legislation has already hurt WuXi AppTec's Hong Kong stock by as much as 33% and its Shanghai stock by about 26% since the beginning of 2024.

The biotechnology company reiterated its opposition of the "biotechnology company of concern" tagging without due process, saying it complies with the laws of the countries it operates in, Yicai said, citing Hu.

Shares in WuXi AppTec rose 1% in Shanghai during Wednesday's trading.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2484361371?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-20 11:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2484361371","market":"hk","top_or_hot":-1,"title":"Market Chatter: US Biosecure Act Passage Still Looms Despite Trump Win, WuXi AppTec Executive Says","media":"MT Newswires Live","content":"<html><body><p> The victory of US President-elect Donald Trump will not directly impact the US Biosecure Act, Yicai Global reported, citing WuXi AppTec (HKG:2359, SHA:603259) Vice Chairman and Chief Investment Officer Hu Zhengguo.</p><p>Passage of the US Biosecure Act, aimed at restricting US federal agencies from transacting with Chinese biotechnology firms due to probable security risks, is still uncertain as Congress adjourns in January 2025, the report said, citing Hu.</p><p>The bill still needs to pass through the Senate before the president signs it into law.</p><p>However, the impending legislation has already hurt WuXi AppTec's Hong Kong stock by as much as 33% and its Shanghai stock by about 26% since the beginning of 2024.</p><p>The biotechnology company reiterated its opposition of the \"biotechnology company of concern\" tagging without due process, saying it complies with the laws of the countries it operates in, Yicai said, citing Hu.</p><p>Shares in WuXi AppTec rose 1% in Shanghai during Wednesday's trading.</p><p>(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Market Chatter: US Biosecure Act Passage Still Looms Despite Trump Win, WuXi AppTec Executive Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMarket Chatter: US Biosecure Act Passage Still Looms Despite Trump Win, WuXi AppTec Executive Says\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-20 11:01 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The victory of US President-elect Donald Trump will not directly impact the US Biosecure Act, Yicai Global reported, citing WuXi AppTec (HKG:2359, SHA:603259) Vice Chairman and Chief Investment ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1046422090.SGD","symbol_name":"Fidelity Pacific A-SGD","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2484361371","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2484361371","pubTimestamp":1732071698,"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"The victory of US President-elect Donald Trump will not directly impact the US Biosecure Act, Yicai Global reported, citing WuXi AppTec  Vice Chairman and Chief Investment Officer Hu Zhengguo.Passage of the US Biosecure Act, aimed at restricting US federal agencies from transacting with Chinese biotechnology firms due to probable security risks, is still uncertain as Congress adjourns in January 2025, the report said, citing Hu.The bill still needs to pass through the Senate before the president signs it into law.However, the impending legislation has already hurt WuXi AppTec's Hong Kong stock by as much as 33% and its Shanghai stock by about 26% since the beginning of 2024.The biotechnology company reiterated its opposition of the \"biotechnology company of concern\" tagging without due process, saying it complies with the laws of the countries it operates in, Yicai said, citing Hu.Shares in WuXi AppTec rose 1% in Shanghai during Wednesday's trading.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"603259":"药明康德","LU1046422090.SGD":"Fidelity Pacific A-SGD","LU2242644610.SGD":"Fidelity China Innovation A-ACC-SGD","LU0456842615.SGD":"JPMorgan Funds - Emerging Markets Equity A (acc) SGD","LU1997245094.SGD":"安联神州A股基金AT Acc SGD","BK0216":"研究试验","BK1583":"高瓴概念","LU2045819591.USD":"Natixis WCM Global Emerging Markets Equity R/A USD","LU0708995583.HKD":"TEMPLETON CHINA \"A\" (HKD) ACC","LU2125910500.SGD":"Natixis WCM Global Emerging Markets Equity H-R/A SGD","LU0320764599.SGD":"FTIF - Templeton China A Acc SGD","LU1997245177.USD":"安联神洲A股基金","LU2488822045.USD":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","BK1141":"生命科学工具和服务","LU0052750758.USD":"富兰克林中国基金A Acc","BK1576":"医药外包概念","02359":"药明康德"},"translate_title":"市场热议：药明康德高管表示，尽管特朗普获胜，美国生物安全法案的通过仍迫在眉睫","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"603259":0.9,"02359":0.9},"content_text":"The victory of US President-elect Donald Trump will not directly impact the US Biosecure Act, Yicai Global reported, citing WuXi AppTec (HKG:2359, SHA:603259) Vice Chairman and Chief Investment Officer Hu Zhengguo.Passage of the US Biosecure Act, aimed at restricting US federal agencies from transacting with Chinese biotechnology firms due to probable security risks, is still uncertain as Congress adjourns in January 2025, the report said, citing Hu.The bill still needs to pass through the Senate before the president signs it into law.However, the impending legislation has already hurt WuXi AppTec's Hong Kong stock by as much as 33% and its Shanghai stock by about 26% since the beginning of 2024.The biotechnology company reiterated its opposition of the \"biotechnology company of concern\" tagging without due process, saying it complies with the laws of the countries it operates in, Yicai said, citing Hu.Shares in WuXi AppTec rose 1% in Shanghai during Wednesday's trading.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2484361371"}